脑部放疗，上午比下午敏感许多！
B4 o5 A" G+ W- {6 C% j" H% J; [8 c& P: }9 e
* R* ]8 F6 X8 e( ], K* H
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
9 B* m; m* t8 @1 M# p& LGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?& E3 g# v" M4 t5 H1 d( `. e2 ]6 o
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.3 V; [1 v4 x* E6 K
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.* D6 e8 [# ^1 a' i7 @2 O3 q/ ]. t" k
+ n" q+ h5 Q/ s. K7 f7 W1 G
Abstract) v, I6 A2 x$ ?" s, O
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.8 X7 N% w: i' p, \' |2 M
& f3 X5 A. m3 d- {7 Q' Q, JMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
6 [$ Z2 S0 |+ N) D; x6 P9 r6 C+ S! [! R6 v% A3 \$ Q1 \# a6 _* X6 y9 r) S
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).6 x. ^! L$ Y( g6 r
/ q- ~* A( ~" p* c& m+ W
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
\4 K' A. G7 O$ ^$ Z9 u7 h5 I$ _3 q) L
|
4 e6 o* |& a1 h+ `3 G. f8 C
显身卡
